Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.semtcvs.2022.03.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Improving Non-Invasive Nodal Staging in Non-Small-Cell Lung Cancer (Commentary re Seder 2024-914).
J Am Coll Surg
December 2024
Jacksonville, FL.
Response to Commentary on "Pitfalls in the Cytological Diagnosis of Nodal Hodgkin Lymphoma".
Diagn Cytopathol
December 2024
Department of Pathology, Government Medical College And Hospital, Chandigarh, India.
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer.
JAMA Surg
December 2024
Department of Surgery, Capio St Göran's Hospital, Stockholm, Sweden.
Importance: In patients with clinically node-negative (cN0) breast cancer and 1 or 2 sentinel lymph node (SLN) macrometastases, omitting completion axillary lymph node dissection (CALND) is standard. High nodal burden (≥4 axillary nodal metastases) is an indication for intensified treatment in luminal breast cancer; hence, abstaining from CALND may result in undertreatment.
Objective: To develop a prediction model for high nodal burden in luminal ERBB2-negative breast cancer (all histologic types and lobular breast cancer separately) without CALND.
Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al.
Int J Gynecol Cancer
October 2024
Gynecologic Oncology Unit, Obstetrics and Gynecology Department, Hospital de la Santa Creu i Sant Pau Servei d'Obstetricia i Ginecologia, Barcelona, Spain.
Shifting neoadjuvant chemotherapy treatment paradigms for breast cancer and its impact on axillary nodal management for clinically node-negative patients.
Gland Surg
July 2024
Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!